CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 238 enrolled
Drug / intervention
genetic diagnosisother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03848455
NCT03848455N/ACompleted
CompareCT.gov

Multi-chip Meta-analysis of Parkinson's Disease for Clinical Validation of Small Samples of Key Genes in Disease

Zhujiang Hospital·observational·Posted Feb 20, 2019·Updated Jul 28, 2023

In Brief

An observational study evaluating genetic diagnosis for Parkinson's Disease. Completed, enrolled 238 participants across 1 site.

Detailed Summary

The research team used meta-analytical statistical methods to integrate the results of different research groups on Parkinson's disease, using meta-analysis to find key genes related to the pathogenesis and development of Parkinson's disease, and to make small clinical results. The verification of the sample, the internal mechanism of the pathogenesis of Parkinson's disease and provide guidance and reference for subsequent experimental research.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 20, 2019
Enrollment StartFeb 25, 2019
Primary CompletionFeb 20, 2021
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 7.4 years ago

Interventions

genetic diagnosisother

The venous blood of the two groups of patients was taken for genetic testing, and the expression levels of PPP2CA, PPP3CB, SYNJ1, NSF and CYCS were extracted by pre-processing the genetic data of PD and non-PD patients.